Navigation Links
Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvania's Review of Proposed Highmark-IBC Merger
Date:1/30/2008

HARRISBURG, Pa., Jan. 30 /PRNewswire/ -- State officials should only approve the proposed merger of Highmark and Independence BlueCross if conditions are attached to enhance health-insurance competition in Pennsylvania, Capital BlueCross President and CEO Anita M. Smith said in state Senate testimony today.

Smith was asked by Committee Chairman Sen. Don White, R-41, to testify about the proposed merger through the lens of the uniquely competitive health- insurance landscape in Central Pennsylvania and the Lehigh Valley.

"The most vibrant health-insurance competition in Pennsylvania today is in the Capital BlueCross service area," Smith said.

"We have learned that competition is healthy. It improves efficiency, innovation, quality and price for consumers and communities in Central Pennsylvania and the Lehigh Valley," Smith said. "It gives more people more choices."

"This Committee has heard previous testimony that a Highmark-Independence Blue Cross merger would not reduce competition, because Highmark and IBC do not currently compete. This misses an essential fact," Smith said. "Highmark and IBC do not compete because they agreed not to compete in 1996. And now that non-compete agreement is expired. If they wanted, they could compete right now. Today. We could have vibrant competition between these companies in southeastern Pennsylvania this very minute. Their merger is their effort to make permanent their agreement not to compete. And they want you to help them do it."

"The importance of state government's decision cannot be overstated," Smith said. "If this merger is approved, without conditions to enhance competition, the rest of the state will be destined to what could become a permanent virtual monopoly. The vibrant competition that exists today in Central Pennsylvania and the Lehigh Valley will never reach the rest of the Commonwealth," Smith said.

"Great attention has been paid to the lure of this transaction -- a purported $1 billion, one-time economic benefit to the Commonwealth. I know this Committee will carefully review that figure. But it also should carefully review what it would have to give up for that money. Pennsylvania's health-insurance market will account for more than $500 billion over the next decade alone. So we respectfully pose the question -- is a one-time payment worth mortgaging the competitive future of this enormous and vital market?

"We believe the answer is no. But what is beyond debate is this: To approve this merger without competition-enhancing conditions would forever close the door on a competitive statewide health-insurance marketplace. Make no mistake: This merger is the Commonwealth's final opportunity. We either nurture vibrant statewide competition. Or we forever preclude it."

For a copy of CEO Smith's testimony, please go to http://www.capbluecross.com.

Capital BlueCross is an independent licensee of the Blue Cross and Blue Shield Association


'/>"/>
SOURCE Capital BlueCross
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: